» Articles » PMID: 35110854

Analysis of Causes of Hepatic Dysfunction in Obstetric Patients in India: A Systematic Review

Overview
Specialty Critical Care
Date 2022 Feb 3
PMID 35110854
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Epidemiology of liver disease in obstetric patients shows geographical variation depending upon the prevalence of preeclampsia, viral hepatitis, and tropical vector-borne diseases like malaria, leptospirosis, etc. We undertook the current systematic review to analyze the causes of hepatic dysfunction in obstetric patients in India and identify the gaps in the literature and reporting.

Materials And Methods: We did a systematic review of studies reporting the causes of hepatic dysfunction in obstetric patients in India. A methodological quality assessment was done using a five-point questionnaire.

Results: A total of 21 studies qualified for evaluation. The rate of hepatic dysfunction among obstetric patients in India ranged from 0.15 to 3.3% with a mean and median rate of 1.49 and 0.93%, respectively. Preeclampsia/HELLP (mean = 36.0%, median = 31.4%, range: 3.6-83.8%) and viral hepatitis (mean = 34.1%, median = 35.5%, range: 5.1-61.8%) were the commonest causes of hepatic dysfunction. Other causes were intrahepatic cholestasis of pregnancy, acute fatty liver of pregnancy, tropical fever (malaria, leptospirosis, dengue, scrub typhus), etc. Maternal mortality ranged from 1.4 to 40% (mean = 12.6%, median = 10.0%) and perinatal mortality was between 16.4 and 38.70% (mean = 31.75%, median = 35.5%).

Conclusion: There is moderate quality evidence to show that preeclampsia/HELLP and viral hepatitis are the commonest causes of hepatic dysfunction in obstetric patients in India.

How To Cite This Article: Ahmed A, Saxena S, Pandey A, Mishra P, Azim A. Analysis of Causes of Hepatic Dysfunction in Obstetric Patients in India: A Systematic Review. Indian J Crit Care Med 2022;26(1):114-122.

Citing Articles

Comparing Feto-Maternal Outcomes in Pregnant Women With Normal and Abnormal Liver Function Tests: A Prospective Observational Study.

Pathak J, Goel N, Jha S, Rani S, Kumari K, Ranjana R Cureus. 2024; 16(3):e56811.

PMID: 38654811 PMC: 11036451. DOI: 10.7759/cureus.56811.

References
1.
Changede P, Chavan N, Raj N, Gupta P . An Observational Study to Evaluate the Maternal and Foetal Outcomes in Pregnancies Complicated with Jaundice. J Obstet Gynaecol India. 2019; 69(1):31-36. PMC: 6361180. DOI: 10.1007/s13224-018-1105-9. View

2.
Denison H, Dodds R, Ntani G, Cooper R, Cooper C, Sayer A . How to get started with a systematic review in epidemiology: an introductory guide for early career researchers. Arch Public Health. 2013; 71(1):21. PMC: 3844862. DOI: 10.1186/0778-7367-71-21. View

3.
Devarbhavi H, Kremers W, Dierkhising R, Padmanabhan L . Pregnancy-associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. J Hepatol. 2008; 49(6):930-5. DOI: 10.1016/j.jhep.2008.07.030. View

4.
Duraiswamy S, Sheffield J, McIntire D, Leveno K, Mayo M . Updated Etiology and Significance of Elevated Bilirubin During Pregnancy: Changes Parallel Shift in Demographics and Vaccination Status. Dig Dis Sci. 2016; 62(2):517-525. DOI: 10.1007/s10620-016-4282-3. View

5.
Suresh I, Tr V, Hp N . Predictors of Fetal and Maternal Outcome in the Crucible of Hepatic Dysfunction During Pregnancy. Gastroenterology Res. 2017; 10(1):21-27. PMC: 5330689. DOI: 10.14740/gr787w. View